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Edited by Ivan SadowskiAbstract CDK11p58, a 58 kDa protein of the PITSLRE kinase
family, plays an important role in cell cycle progression, and is
closely related to cell apoptosis. To gain further insight into
the function of CDK11p58, we screened a human fetal liver
cDNA library for its interacting proteins using the yeast two-
hybrid system. Here we report that histone acetyltransferase
(HAT) HBO1, a MYST family protein, interacts with
CDK11p58 in vitro and in vivo. CDK11p58 and HBO1 colocalize
in the cell nucleus. Recombinant CDK11p58 enhances the HAT
activity of HBO1 signiﬁcantly in vitro. Meanwhile, overexpres-
sion of CDK11p58 in mammalian cells leads to the enhanced
HAT activity of HBO1 towards free histones. Thus, we conclude
that CDK11p58 is a new interacting protein and a novel regulator
of HBO1. Both of the proteins may be involved in the regulation
of eukaryotic transcription.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cyclins and their cyclin-dependent kinase (CDK) partners
play two major roles in eukaryotic cells. Cyclin B/CDK1, cy-
clin A/CDK2, 3, cyclin D/CDK4, 6, and cyclin E/CDK2 are in-
volved in regulating the cell cycle [1–6], while cyclin H/CDK7,
cyclin C/CDK8, and cyclin T/CDK9 are primarily involved in
regulating transcription [7–9], although other functions of
CDKs may yet be unknown.
CDK11 isoforms, also named PITSLRE protein kinases for
the conserved PITSLRE motif in their kinase domains, are en-
coded by two highly homologous p34cdc2-related genes,
Cdc2L1 and Cdc2L2, which are located on human chromo-
some 1p36.3 [10]. Cyclin D3 is the cyclin partner of CDK11p58,
while cyclin L is the cyclin partner of CDK11p110 [11,12]. At
least 10 CDK11 isoforms have been cloned from eukaryotic
cells, with their molecular weights varying from 46 to
110 kDa [13]. CDK11p110 and CDK11p58 are translated from
a single transcript by initiation at alternative in-frame AUG
codons [14]. The other smaller members of CDK11 superfam-*Corresponding author. Fax: +86 21 64164489.
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spliced isoforms of the larger 110 kDa isoforms. Unlike other
CDK11 family proteins, CDK11p58 is speciﬁcally expressed in
G2/M phase of the cell cycle [15]. CDK11
p110/p58 kinases are
essential for cellular viability as well as normal early embry-
onic development [16]. Ectopic expression of CDK11p58 in
Chinese hamster ovary ﬁbroblasts results in prolonged late
telophase, abnormal chromosome segregation, and decreased
cell growth rates due to apoptosis [17]. The induction of pro-
tein kinase activity of CDK11p110/p58 and the increasing levels
of smaller isoforms of CDK11 due to the induction of caspase-
mediated cleavage were found in Fas mAb treated Jurkat cells
[18,19]. Our previous study demonstrated that upon the inter-
action with CDK11p58 in G2/M phase, cyclin D3 accelerated
the translocation of CDK11p58 towards the nucleus and acti-
vated the histone H1 kinase activity of CDK11p58 [11].
Many eﬀorts have been made to reveal the relationship be-
tween CDK11 family proteins and transcriptional regulation
in eukaryotic cells. CDK11p110 protein kinases associate with
RNA polymerase II (RNAP II) complexes [20]. Antibody-
mediated inhibition of CDK11 kinases speciﬁcally suppressed
RNAP II-dependent transcription in vitro. CDK11p110 iso-
forms also interact with pre-mRNA splicing factors including
cyclin L, RNPS1, 9G8, ELL2, TFIIF, TFIIS and FACT,
and promotes pre-mRNA processing [12,21–23]. We have re-
ported that cyclin D3, the cyclin partner of CDK11p58, inter-
acts directly with human Activating Transcription Factor 5
(hATF5), and enhances its transcription activity [24]. All these
data suggest that members of CDK11 are associated with tran-
scriptional regulation as well as cell cycle progression.
The acetylation of histones by HATs has been well docu-
mented to confer a regulatory function on transcription.
HBO1 (histone acetyltransferase binding to ORC1) was identi-
ﬁed as a new MYST family histone acetyltransferase in 1999
[25]. It was previously found to exist as a part of a multisubunit
complex that possess histoneH3 andH4 acetyltransferase activ-
ities. All theMYSTproteins including the humanproteinsMOZ
(monocytic leukemia zinc ﬁnger protein),MORF (MOZ-related
factor), and Tip60 (HIV Tat-interacting protein of 60 kDa),
Drosophila MOF (males-absent on the ﬁrst), yeast proteins
SAS2 and SAS3 (something about silencing) and Esa1 (essential
SAS family acetyltransferase) contain an atypical C2HC zinc
ﬁnger and a putative HAT domain [26–31]. Unlike other HAT
families, most MYST proteins have not shown the intrinsic
HAT activity towards the nucleosomal histones that are directly
involved in transcriptional activation [25]. SomeMYST histoneblished by Elsevier B.V. All rights reserved.
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transactivation. The interacting proteins of HBO1 include rep-
lication factors MCM2 and ORC1, and the androgen receptor,
a member of the nuclear receptor superfamily. Thus, HBO1 is
involved in a wide range of regulatory functions fromDNA rep-
lication to RNA transcription [32,33,25].
Many histone acetyltransferases act as co-factors in tran-
scription, and are regulated by certain proteins. But no protein
has yet been found to regulate the activity of HBO1. Here, we
demonstrate that CDK11p58 is a new identiﬁed interacting pro-
tein of HBO1 and enhances its HAT activity.2. Materials and methods
2.1. Materials
The human prostate cancer cells PC-3, DU-145 cells, HeLa and
COS-1 cells, were obtained from the Institute of Cell Biology Aca-
demic Sinica. Dulbeccos modiﬁed Eagles medium (DMEM) was from
Sigma. MATCHMAKER LexA two-hybrid system, human fetal liver
MATCHMAKER LexA cDNA library and mouse monoclonal anti-
LexA antibody were products of Clontech. LipofectAMINEe Re-
agent and rabbit polyclonal anti-myc antibody were purchased from
Invitrogen. Monoclonal anti-HA antibody, PVDF membrane, leupep-
tin, aprotinin, and phenylmethylsulfonyl ﬂuoride were purchased from
Roche. Polyclonal anti-HBO1, anti-PITSLRE antibodies, HRP or
rhodamine conjugated goat anti-mouse, goat anti-rabbit horseradish
peroxidase, and mouse anti-goat-FITC secondary antibody were from
Santa Cruz Biotechnology. The enhanced chemiluminescence (ECL)
assay kit, [3H] acetyl-coenzyme A, [14C] acetyl-coenzyme A and [35S]
methionine were purchased from Amersham Biosciences. TNT cou-
pled reticulocyte lysate system was bought from Promega.2.2. Plasmid construction
The human CDK11p58 cDNA was cloned into HA- or GST-tagged
pcDNA3 (Invitrogen), pLexA and pB42AD (Clontech) vectors as de-
scribed [11]. NTD (1–100 amino acids), DCTD (1–389 amino acids),
DNTD (66–439 amino acids), PKD (66–389) and CTD (374–439 ami-
no acids) representing the ﬁve deletion mutants of CDK11p58 were in-
serted in pcDNA3-GST vectors and downstream of the DNA-binding
domain in pLexA. GST fusion vector pGEX-CDK11p58 was con-
structed by subcloning an EcoRI/XhoI fragment of CDK11p58 into
the same sites of pGEX4T-1 (Amersham).
Human HBO1 from pET11cGST-HBO1 (provided by Dr. Bruce
Stillman, Cold Spring Harbor Laboratory, USA) was subcloned into
the BamHI/HindIII site of pcDNA3.1/myc-His()A vector (Invitro-
gen). N-terminal fragment (NTD, 1–329 amino acids), serine-rich do-
main (SRR, 1–170 amino acids), MYST domain (MYST, 330–611
amino acids), zinc ﬁnger-containing domain (ZNF, 330–450 amino
acids) and motif A-containing domain (MTA, 451–611 amino acids)
of HBO1 were cloned in pcDNA3-GST and pB42AD vectors.
2.3. Yeast two-hybrid assays
Yeast two-hybrid screen was performed as described [11]. The
cDNA library from human fetal liver (Clontech) was used in this
screen. The pLexA and pB42AD constructs were co-transformed into
EGY48 yeast strain using the lithium acetate method according to the
manufacturers instructions. Transformed yeast cells were plated in
selective medium lacking tryptophan, leucine and histidine and supple-
mented with 0.08 mg/ml X-Gal. The speciﬁc interaction was quanti-
tated by the activation of the reporter genes LEU2 and lacZ.
2.4. Cell culture, transfection and synchronization
HeLa and COS-1 cells were maintained in DMEM supplemented
with 10% fetal calf serum (FCS), 100 U/ml of penicillin and 50 lg/ml
of streptomycin. PC-3 and DU-145 cells were cultured in F12 contain-
ing 10% FCS, 100 U/ml of penicillin and 50 lg/ml of streptomycin.
Approximately 3 · 106 cells were plated on 100 mm dishes 24 h before
transfection. 8 lg of total plasmids and 30 ll of LipofectAMINE re-
agent were used according to the manufactures instructions.G1/S phase-arrested HeLa cells were obtained by sequential thymi-
dine treatment as described [11]. To block cells in G2/M phase, cells
were treated with 50 ng/ml nocodazole in DMEM with 10% FCS for
16 h.
2.5. GST-pull down experiments
GST-fused CDK11p58 and its deletion mutants were expressed in
Escherichia coli. HBO1 was in vitro translated and 35S labeled methi-
onine with the TNT coupled reticulocyte lysate system. Labeled
HBO1 and GST-fused CDK11p58 or its mutants were incubated to-
gether with glutathione–Sepharose beads in the binding buﬀer
(20 mM Tris, pH 7.5, 50 mM NaCl, 10% glycerol, 10 mM NaF, 1%
Nonidet P-40, 1 mM NaVO4, 10 lg/ml aprotinin, 10 lg/ml leupeptin
and 1 mM PMSF) at 4 C for 4 h with gentle rotation. The beads were
washed three times with the same buﬀer. Bound proteins were sub-
jected to 10% SDS–PAGE. The gel was then dried and visualized with
phosphoimaging (Fujiﬁlm). Binding assays with in vitro translated
GST-HBO1 or its deletion mutants and 35S labeled methionine
CDK11p58 were also performed as described above.
2.6. Immunoprecipitation and nuclear extraction
After treatment with nocodazole or thymidine, or 48 h after trans-
fection, the cells were washed three times with ice-cold PBS and solu-
bilized with 1 ml of lysis buﬀer (50 mM Tris–HCl, pH 7.5, 150 mM
NaCl, 0.1% Nonidet P-40, 5 mM EDTA, 5 mM EGTA, 15 mM
MgCl2, 60 mM b-glycerophosphate, 0.1 mM sodium orthovanadate,
0.1 mM NaF, 0.1 mM benzamide, 10 lg/ml aprotinin, 10 lg/ml leu-
peptin and 1 mM PMSF). Detergent-insoluble materials were removed
by centrifugation at 12000 · g for 10 min at 4 C. Whole cell lysates
were incubated with rabbit polyclonal anti-myc antibody (Santa Cruz)
at 4 C for 1 h. Pre-equilibrated protein G–agarose beads (Roche) were
then added and incubated at 4 C overnight. The beads were collected
by centrifugation and then gently washed three times with the lysis buf-
fer. The bound proteins were eluted by boiling in SDS sample buﬀer
and resolved on a 10% SDS–PAGE gel. The proteins were transferred
onto a PVDF membrane and immunoblotted with mouse anti-HA
monoclonal antibody (Roche).
1 · 107 cells were collected for nuclear extraction. Cytoplasmic and
nuclear fractions were extracted with nuclear extraction kit (Active
Motif) according to the manufacturers manual and stored at 70 C
for further analysis.
2.7. Immunoﬂuorescence staining
HeLa cells were plated onto coverslips the day before transfection.
48 h after transfection with HA-CDK11p58, cells were ﬁxed in ice-cold
4% polyformaldehyde for 30 min and blocked in PBS containing 1%
BSA for 1 h followed by incubation with mouse monoclonal anti-HA
and goat anti-HBO1 antibodies at room temperature for 2 h. The cov-
erslips were then rinsed three times in PBS and reacted for 1 h with goat
anti-mouse IgG-Rhodamine and mouse anti-goat IgG-ﬂuorescein iso-
thiocyanate (FITC) in a dark chamber. The coverslips were washed as
described above, inverted, mounted on slides, and examined in a Zeiss
confocal microscope. Digitized images of the ﬂuorescent-antibody-
stained cells were obtained with software provided by Zeiss.2.8. Histone acetyltransferase activity assay
Cells plated on 100 mm dishes were collected and solubilized with ly-
sis buﬀer. 500 lg of total cell lysates was used to immunoprecipitate
endogenous HBO1 with rabbit anti-HBO1 polyclonal antibody and
protein G–agarose beads as described above. Beads were extensively
washed three times with lysis buﬀer and two times with 1 · HAT buﬀer
(50 mM Tris–HCl, pH 8.0, 1 mM DTT, 0.1 mM EDTA, 10 mM so-
dium butyrate and 10% glycerol). HAT reactions were carried out with
5 lg whole histones from calf thymus (Sigma, type II-A), 250 nCi [3H]
acetyl-coenzyme A in 30 ll 1 ·HAT buﬀer for 60 min at 30 C with
frequent agitation. Reactions were stopped by spotting the superna-
tants onto P81 paper (Whatman). The ﬁlters were washed three times
in 50 mM sodium carbonate (pH 9.2), air dried and subjected to scin-
tillation counting. Alternatively, HAT reactions were carried out using
100 nCi [14C] acetyl-coenzyme A, and were terminated by addition of
SDS sample buﬀer followed by 15% SDS–PAGE gel. After staining
of the histones with Coomassie blue, the gels were visualized by phos-
phoimaging.
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3.1. CDK11p58 interacts with histone acetyltransferase HBO1 in
yeast
We have previously carried out a yeast two-hybrid screen
to identify the interacting proteins of CDK11p58. Two of
the 19 positive clones were identiﬁed as the conserved MYST
domain of HBO1 (330–611aa), an MYST family histone
acetyltransferase. Other members of the MYST HAT family
include yeast Esa1, Drosophila MOF, and human MORF,
etc. [28–30]. A C2HC zinc ﬁnger and a putative acetyl-
coenzyme A-binding motif (Motif A) were involved in this
region (Fig. 1A).
CDK11p58 contains a c-terminal conserved p34cdc2-related
Ser/Thr protein kinase catalytic domain and a unique putative
calmodulin-binding site located in its N-terminal region [17].
Thus, variant truncated fragments of CDK11p58 were cloned
into pLexA vector and were co-transformed with pB42AD-
HBO1 in yeast EGY48 cells. Only full-length CDK11p58 was
capable of activating the two reporter genes, LEU and LacZ,
with HBO1 (Fig. 1B). Similarly, HBO1 and its deletion con-
structs were inserted into pB42AD and were co-transformed
with pLexA-CDK11p58, respectively, in the yeast. The result
showed that the MYST domain of HBO1 was the minimal
fragment that could interact with CDK11p58 in yeast (Fig.
1A). Immunoblotting indicated that deletions of pB42AD-
HBO1 and pLexA-CDK11p58 were expressed at similar levels
in yeast (Fig 1A and B, lower panels).Fig. 1. CDK11p58 interacts with HBO1 in yeast. (A) Mapping the
region of HBO1 that interacts with CDK11p58. Deletion mutants of
HBO1 were constructed in pB42AD according to the domains
indicated. Constructs were tested for interaction with pLexA-3.2. CDK11p58 binds to HBO1 in vitro
To support the direct binding between CDK11p58 and
HBO1, an in vitro GST-pull down assay was used. GST-
CDK11p58 and its deletions were expressed in E. coli. and were
puriﬁed with glutathione–Sepharose beads (Fig. 2A, lower pa-
nel). HBO1 was labeled with [35S] methionine in vitro and
incubated with either full-length GST-CDK11p58 or its variant
fragments and glutathione–Sepharose beads. As a result,
HBO1 only interacted with full-length GST-CDK11p58 in vitro,
but did not associate with any deletion mutants of CDK11p58
(Fig. 2A).
GST-fused HBO1 and its deletions were translated in vitro
(Fig. 2B, lower panel). CDK11p58 was 35S labeled methionine
and incubated with full-length HBO1 or its deletion mutants,
respectively. Consistent with the results found in yeast, both
full-length HBO1 and its MYST domain bound to
CDK11p58 (Fig. 2B). Thus, the MYST domain of HBO1 is
essential for the interaction between HBO1 and CDK11p58,
while the full length of CDK11p58 is necessary for its binding
to HBO1.CDK11p58 in yeast. SRR, serine-rich region; NTD, N-terminal
domain; MYST, MYST domain; ZNF, zinc ﬁnger motif; MTA,
acetyl-coenzyme A binding motif. Yeast strains that were transformed
with pB42AD-HBO1 and its deletions were lysed and immunoblotted
with anti-HA antibody. (B) Mapping the region of CDK11p58 that
interacts with HBO1. Five deletions of CDK11p58 were inserted into
pLexA to determine the interaction with pB42AD-HBO1 in yeast.
NTD, N-terminal domain; CTD, C-terminal domain; DNTD, N-
terminal domain-deleted mutant; DCTD, C-terminal domain-deleted
mutant; PKD, Ser/Thr protein kinase domain. Yeast strains that were
transformed with pLexA-CDK11p58 deletions were immunoblotted
with anti-LexA antibody.3.3. CDK11p58 associates with HBO1 in mammalian cells
HA-CDK11p58 was co-transfected with myc-HBO1 or
pcDNA3.1-myc vector into HeLa cells. The whole cell lysates
were incubated with rabbit anti-myc antibody followed by
blotting with mouse monoclonal anti-HA and anti-myc anti-
bodies. HA-CDK11p58 was co-immunoprecipitated with
myc-HBO1 in HeLa cells (Fig. 3A, lane 4).
Since endogenous CDK11p58 is expressed exclusively in
G2/M phase, HeLa cells were arrested in G2/M or G1/S phase.
Cell lysates were immunoprecipitated with anti-PITSLRE
antibody or rabbit control IgG. HA-CDK11p58 transfected cell
Fig. 2. CDK11p58 interacts with HBO1 in vitro. (A) GST-tagged CDK11p58 and its deletion mutants were expressed in E. coli and puriﬁed with
glutathione–Sepharose beads, then incubated with 35S labeled methionine HBO1, respectively. Proteins bound to the beads were subjected to 10%
SDS–PAGE gel and analyzed by phosphoimaging (upper panel). Protein loading of CDK11p58 and its fragments were determined by staining with
Coomassie brilliant blue (lower panel). (B) pcDNA3-GST-HBO1 and its deletion mutants were translated with TNT-coupled reticulocyte lysate
system in vitro. CDK11p58 was labeled with [35S] methionine. GST-pull down experiment was carried out as described in Section 2. Bound CDK11p58
was detected by phosphoimaging (upper panel). To verify the expression of pcDNA3-GST-HBO1 and its fragments in TNT system, the proteins were
35S labeled methionine and viewed by autoradiography (lower panel).
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proteins were blotted with anti-HBO1 antibody. CDK11p58
was expressed exclusively in G2/M arrested HeLa cells as re-
ported (Fig. 3B, lower panel). HBO1 was co-immunoprecipi-
tated with CDK11p58 in G2/M arrested HeLa cells (Fig. 3B,
lane 3). Although CDK11p110 was expressed throughout the
whole cell cycle, interaction between endogenous HBO1 and
CDK11p110 was not detected in G1/S arrested cells (Fig. 3B,lane 2). As expected, co-immunoprecipitation of HBO1 and
CDK11p58 was found in HA-CDK11p58 transfected HeLa cells
(Fig. 3B, lane 4).
3.4. CDK11p58 colocalizes with HBO1 in the nucleus
To further prove the association of HBO1 with CDK11p58 in
mammalian cells, HA-CDK11p58 or pcDNA3-HA vector were
transfected in HeLa cells to observe their colocalization with
Fig. 3. CDK11p58 interacts with HBO1 in mammalian cells. (A) Ectopically expressed HA-CDK11p58 interacted with HBO1 in HeLa cells. HeLa
cells were transiently transfected with HA-CDK11p58 and myc-HBO1 or pcDNA3.1-myc vector. Immunoprecipitation was performed with rabbit
polyclonal anti-myc antibody. Co-immunoprecipitated proteins were probed with anti-myc and mouse monoclonal anti-HA antibodies.
(B) Endogenous CDK11p58 interacted with HBO1 in vivo. HeLa cells were synchronized to G1/S phase or G2/M phase. Cell lysates were
immunoprecipitated with anti-PITSLRE antibody. Co-immunoprecipitated proteins were blotted with anti-HBO1 antibody (upper panel). Rabbit
control IgG was used as a negative control. HA-CDK11p58-transfected HeLa cells were used as a positive control. 10% of whole cell lysates (WCL)
was immunoblotted with anti-PITSLRE to identify the expression of CDK11p110 (middle panel) and CDK11p58 (lower panel).
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located in the nucleus (panel II and V). More than 80% of
HA-CDK11p58 was located in the nucleus (panel IV). When
the images were merged, CDK11p58 and HBO1 were observed
as particles in the cell nucleus (panel VI). pcDNA3-HA vector
transfected HeLa cells showed weak and diﬀused background
when stained with anti-HA antibody and no colocalization with
HBO1 was found (panel I and III). This immunoﬂuorescence
provides evidence that the functions of CDK11p58 and HBO1
may be closely related to nuclear activities including DNA rep-
lication, transcription and RNA processing. Western blotting
also revealed that both CDK11p58 and HBO1 were mainly ex-
pressed in the nucleus. Unlike CDK11p58, HBO1 was expressed
at similar levels throughout the whole cell cycle (Fig. 4B).3.5. CDK11p58 enhances the histone acetyltransferase activity of
HBO1 in vitro
Protein kinases usually function in signaling pathways, while
many histone acetyltransferases act as co-factors involved in
the direct regulation of transcription. It has been reported that
some HATs are regulated by protein kinases. For example,RSK2, a member of kinases downstream of the MAPKs, inter-
acts with CBP and impairs its HAT activity in a dose-depen-
dent manner [34]. Although the precise roles of HBO1 in
DNA replication and transcription remain unknown, it is pos-
sible that these functions are associated with its HAT activity.
The region of HBO1 responsible for its interaction with
CDK11p58 was the MYST domain, in which the HAT activity
of HBO1 was implicated. Thus, we wondered whether
CDK11p58 regulated the HAT activity of HBO1 upon their
interactions in vitro and in vivo.
HBO1 was immunoprecipitated from HeLa cell lysates with
anti-HBO1 antibody to test its intrinsic HAT activity. Increas-
ing amount of puriﬁed GST-CDK11p58 protein were added
into the reaction system. GST protein was added as a negative
control. Free histones from calf thymus and [14C] acetyl-CoA
were used as substrates of HBO1. Acetylated histones were
analyzed by SDS–PAGE and phosphoimaging. A ﬁlter bind-
ing HAT activity assay was also employed to quantitate
HBO1 HAT activity. As indicated in Fig. 5A, HBO1 acety-
lated histone H3, H4 and, more weakly, H2A as reported
[25]. Scintillation counting of the bound [3H] acetyl-CoA
showed that the presence of recombinant CDK11p58 enhanced
Fig. 4. CDK11p58 colocalizes with HBO1 in the cell nucleus. (A) CDK11p58 and HBO1 colocalized in the nucleus. HA-CDK11p58 (lower panels) or
pcDNA3-HA vector (upper panels) were transiently transfected in HeLa cells. 48 h after the transfection, cells were ﬁxed and reacted with mouse
anti-HA monoclonal antibody and goat anti-HBO1 polyclonal antibody followed by incubation with rhodamine-conjugated goat anti-mouse IgG
and FITC-conjugated mouse anti-goat IgG secondary antibodies. Images were captured and analyzed with a Zeiss confocal microscope (40· zoom).
(B) HeLa cells were synchronized to G1/S phase and G2/M phase. Nuclear and cytoplasmic fractions of synchronized and asynchronous cells were
immunoblotted with anti-PITSLRE and anti-HBO1 antibodies.
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while GST did not aﬀect HBO1 HAT activity (Fig. 5B). HBO1
HAT activity was enhanced by nearly 1.7-fold when 1.5 lg of
recombinant CDK11p58 protein was added. The activation is
speciﬁc since no increase was observed in p300 HAT activity
in the presence of recombinant CDK11p58. The activation of
HBO1 HAT activity by CDK11p58 might be kinase activity-
independent because no ATP was present is this in vitro assay.
As we expected, the addition of ATP did not further potentiate
the HAT activity of HBO1 (Fig. 5C).
3.6. CDK11p58 enhances the histone acetyltransferase activity of
HBO1 in vivo
CDK11p58 was transiently transfected into HeLa cells.
Endogenous HBO1 was immunoprecipitated to evaluate the
activation of HBO1 HAT activity by CDK11p58 in vivo. Coin-
cidently, ectopically expressed CDK11p58 enhanced HBO1
HAT activity in HeLa cells, although less signiﬁcantly than di-
rect addition of recombinant CDK11p58 in vitro (Fig. 6A).
HBO1 HAT activity increased by 30% in HeLa cells which
were transfected with 1 lg HA-CDK11p58 plasmid. But the
dose–eﬀect relationship was not so obvious as that was seen
in the in vitro HAT assays. Transfection of pSV-CDK11p110
did not aﬀect the HAT activity of HBO1 in vivo at all(Fig. 6B). The activation of HBO1 HAT activity was also seen
in CDK11p58-transfected COS-1, PC-3 and DU-145 cells
(Fig. 6C) in which interactions between ectopically expressed
CDK11p58 and HBO1 were also observed (data not shown).
Thus, we concluded that binding of CDK11p58 to HBO1 acti-
vated the HAT activity of HBO1 and consequently regulated
the biological function of this histone acetyltransferase.4. Discussion
It is becoming increasingly clear that CDK11p58 is closely re-
lated to cell cycle, apoptotic signaling and tumorigenesis
[17,35–39]. But the molecular mechanisms remain unknown.
CDK11p58 interacts with cyclin D3 in G2/M phase, resulting
in the activation of its kinase activity and its accumulation in
the nucleus [11]. When cells were treated with anti-Fas anti-
body, the induction of CDK11 histone H1 kinase activity
was observed and the larger forms of CDK11 including p58
and p110 were cleavaged to CDK11p50. We have documented
that CDK11p50 interacts with PAK1, inhibits its kinase activity
and induces apoptosis [40]. Other research groups reported
that activated PAK1 protects cells from apoptosis, and this
is mediated, at least in part, through the suppression of the
Fig. 5. CDK11p58 enhances HBO1 HAT activity in vitro. (A) HBO1 was immunoprecipitated from HeLa cells lysates with anti-HBO1 antibody.
HAT activity was assayed with [14C] acetyl-coenzyme A and free calf thymus histones. Increasing amounts of recombinant CDK11p58 were added in
the HAT reactions. Acetylation of histones by HBO1 was analyzed by SDS–PAGE and phosphoimaging (upper panel). Histones were stained with
Coomassie brilliant blue (middle panel). 5% loading of whole cell lysates was probed with anti-HBO1 antibody (lower panel). (B) Filter binding
HBO1 HAT activity was assayed with [3H] acetyl-coenzyme A, free calf thymus histones and increasing amount of recombinant CDK11p58. Filters
were counted using liquid scintillation. p300 HAT activity in the presence or absence of recombinant CDK11p58 was also assayed. (C) Filter binding
HBO1 HAT activity was assayed as described in B except that ATP was added as indicated. The data are presented as the mean values ± standard
deviation of three independent experiments.
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tone acetyltransferase HBO1 is a new interacting protein of
CDK11p58. CDK11p58 enhances the intrinsic HAT activity of
HBO1 upon their interaction in cells. Since HBO1 is a poten-
tial negative regulator, CDK11p58 may also have a repressing
role in the transcription of certain genes which are closely re-
lated to cell cycle progression or apoptosis.
More and more reports have demonstrated that some cyclins
and CDKs play important roles in transcription regulation.
The association of cyclin D3 with transcription factor hATF5
and binding of the 110 kDa isoforms of CDK11 to RNAP II-
containing transcription complexes and pre-mRNA splicing
factors including RNPS1, cyclin L, FACT imply the potential
role of CDK11p58 in transcription regulation. During the studyof the mechanisms by which CDK11p58 arrests the cell cycle
and accelerates apoptosis, we found HBO1, a member of
MYST family HATs, was a novel interacting protein of
CDK11p58. CDK11p58 interacts with HBO1 in the mammalian
cell nucleus and enhances HBO1 HAT activity towards free
histones in a dose-dependent manner. Although most func-
tions of CDK11 are associated with their kinase activities,
the enhancement of HBO1 HAT activity may be kinase activ-
ity-independent, because addition of recombinant CDK11p58
in the absence of ATP in vitro signiﬁcantly enhanced the
HAT activity of HBO1. Furthermore, addition of ATP has
no further eﬀect on the activation of HBO1 HAT activity by
CDK11p58. These results suggest that the three-dimensional
structure of HBO1 may be altered upon the direct association
Fig. 6. CDK11p58 enhances HBO1 HAT activity in vivo. (A) After transfection of CDK11p58, HBO1 was immunoprecipitated from cell lysates.
HAT activity was assayed by ﬁlter binding HAT assays. Western blotting showed the expression of HBO1 and HA-CDK11p58 (lower panel). (B)
pSV-CDK11p110 was transfected with increasing amounts into HeLa cells. HBO1 HAT activity was assayed as mentioned above. (C) HBO1 HAT
activity was assayed in HA-CDK11p58-transfected COS-1, PC-3 and DU-145 cells. The data are presented as the mean values ± standard deviation of
three independent experiments.
3586 H. Zong et al. / FEBS Letters 579 (2005) 3579–3588with CDK11p58, resulting in its elevated HAT activity. Thus,
HBO1 may be a downstream eﬀector of a CDK11p58 signaling
pathway.
It is well known that acetylation of core histones by HATs is
involved in transcription regulation. These HATs includingCBP, p300, PCAF, hTAFII250, steroid receptor coactivator
1 (SRC1) and activator of thyroid and retinoic acid receptor
(ACTR) appear to be recruited by a large number of DNA-
sequence-speciﬁc transcription factors, and act as co-factors
[43,44]. Since the HBO1-containing complex has shown weak
H. Zong et al. / FEBS Letters 579 (2005) 3579–3588 3587HAT activity towards the nucleosomal histones that are di-
rectly involved in transcriptional activation, it is likely that
the regulatory function of HBO1 is associated with its HAT
activity [25]. CDK11p58 enhances HBO1 HAT activity mark-
edly in vitro and more modestly in vivo. HBO1 is involved
in the repression of AR-mediated transactivation [33]. The
truncated HBO1 containing only the ﬁrst 360 amino acids is
competent for the transcriptional repression function, while
the deletion of the ﬁrst 230 amino acids abrogates the repres-
sion activity of HBO1. Thus, HBO1 HAT activity may be
unrelated to the repression of AR-mediated transactivation.
But the possibility that CDK11p58 may regulate AR-mediated
transcription through the modulation of HBO1 function can-
not be excluded.
Recent data demonstrate that these histone-acetylating,
transcriptional adaptor proteins are parts of large multiprotein
complexes [45]. The role of HBO1 in transcription repression
of AR suggests that CDK11p58 may also play important roles
in the regulation of AR-mediated transactivation. Since acety-
lation of core histones is often thought to be linked to transac-
tivation, HBO1 may act as a protein factor acetyltransferase
rather than a histone acetyltransferase. Upon binding to
HBO1, CDK11p58 activates its HAT activity. The activated
HBO1 HAT activity then leads to the hyper-acetylation of cer-
tain proteins including transcription factors or co-factors,
through which the repressive activities of HBO1 and
CDK11p58 are exerted.
Considering the repressive eﬀect of the two proteins and the
deletion of CDK11p58 in some cancers, CDK11p58 and HBO1
may act as inhibitors of cell growth and may contribute to the
apoptosis or negative regulation of some cancer cells.
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